BriteVu proved to be an practical and versatile choice for a contrast agent. It was used in a series of studies involving perfusions as part of an effort to characterize the effect of a commercial drug candidate on vascular development. Ease of preparation and cost efficiency make it an excellent option for exploratory research.

Nikita Kondratiev

Senior Research Associate- Keros Therapeutics

Leave a Reply